日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
2011/04/08 | 04 : 04 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
2011/04/08 | 03 : 55 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
2011/04/08 | 03 : 45 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
2011/04/08 | 03 : 19 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
2011/04/08 | 01 : 35 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
2011/04/08 | 01 : 16 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
2011/04/06 | 05 : 53 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
2011/04/06 | 05 : 52 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
2011/04/06 | 05 : 39 | Business Wire | CPEX Completes Sale to FCB I Holdings | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
2011/04/06 | 04 : 59 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
2011/04/06 | 04 : 56 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
2011/04/06 | 03 : 46 | Edgar (US Regulatory) | Statement of Ownership (SC 13G) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
2011/04/06 | 03 : 42 | Edgar (US Regulatory) | Statement of Ownership (SC 13G) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
2011/04/06 | 02 : 53 | PR Newswire (US) | Footstar Completes Acquisition of CPEX Pharmaceuticals, Inc. | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
2011/03/31 | 23 : 54 | Edgar (US Regulatory) | Annual Report (10-K) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
2011/03/30 | 23 : 11 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
2011/03/24 | 22 : 21 | Business Wire | CPEX Stockholders Approve $27.25 Per Share Merger Agreement with FCB I Holdings | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
2011/03/24 | 04 : 00 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
2011/03/23 | 20 : 00 | Business Wire | CPEX Urges Stockholders to Consider the Facts of the Certain All-Cash FCB Transaction | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
2011/03/23 | 19 : 02 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
2011/03/22 | 21 : 30 | PR Newswire (US) | Mangrove Partners Notes CPEX Stock Trading Above Offer Price | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
2011/03/22 | 05 : 31 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
2011/03/22 | 00 : 56 | Business Wire | CPEX Advises Stockholders to Vote Today for the All-Cash, Premium FCB Transaction | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
2011/03/21 | 21 : 30 | PR Newswire (US) | Mangrove Partners Expresses Disappointment in Board of CPEX Pharmaceuticals, Inc. and Reaffirms Proposed Recapitalization and In | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
2011/03/19 | 05 : 27 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
2011/03/19 | 05 : 21 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
2011/03/18 | 22 : 36 | Business Wire | CPEX Pharmaceuticals Affirms Recommendation That Stockholders Vote for Merger Agreement With FCB | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
2011/03/18 | 06 : 13 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
2011/03/18 | 06 : 09 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
2011/03/17 | 22 : 34 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |